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Delirium

Key predisposing and precipitating factors for delirium
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Predisposing factors
C
C

Abstract

C

Delirium is a common neuropsychiatric syndrome and can occur in various
clinical settings. It has a multi-factorial aetiology. It is associated with
increased morbidity and mortality. Tools and strategies to screen and
assess the severity of delirium can be used for an early intervention.
Proactive screening for delirium has the potential to allow more optimal
management, and thereby reduce morbidity and mortality significantly.
Appropriate drug therapy may form part of multi-component interventions
in the prevention and treatment of delirium. Further research is warranted
in the systematic identification of high-risk patients undergoing major
procedures as well as in the prophylactic or pre-emptive use of appropriate drugs and dosages.
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Advanced age
Male sex
Visual impairment
Presence of
dementia
Severity of
dementia
Depression
Immobility
Dehydration
Metabolic
abnormalities
Alcohol misuse
Narcotics, sedatives
Anaemia
Pain
Malnutrition

Precipitating factors
C
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Acute illness
Severity of physical illness
Infection, especially urinary
tract
Hyponatremia
Shock
Immobilization and physical
restraint
Bladder catheterization
Surgery
Intensive care unit admission
Medication, changes and
additions

Table 1

Definition

substance-induced delirium; delirium due to multiple aetiologies;
and delirium not otherwise specified. The International Classification of Diseases (ICD-10)9 classifies delirium under two separate categories: mainly substance-induced; and organic (nonsubstance) mental disorder.
The presence of certain risk factors increases the risk of developing delirium.10,11 Several predisposing or precipitating aetiological factors have been considered and are shown in Table 1.
Development of delirium has also been described in light of these
vulnerability factors and noxious insults.12 For example, an elderly
person with pre-existing cognitive impairment and poor physical
health can be considered vulnerable to the development of
delirium in association with, say, a urinary tract infection. Similarly, a high-risk noxious insult, such as major surgery, in a relatively healthy person can assist in precipitating delirium.

Delirium is an acute neuropsychiatric syndrome but is chiefly
a reversible change in consciousness with change in cognition,
such as memory deficit, disorientation and language disturbance,
with such perceptual impairments as illusions and hallucinations. In contrast dementia is a progressive, irreversible and
chronic alteration in cognition.

Epidemiology
Delirium is a complex and understudied neuropsychiatric
syndrome that occurs in 11e42% of general medical inpatients1
and up to 50% of the hospitalized elderly.2 Milder forms of
delirium with impaired consciousness are likely to be missed in
busy inpatient settings. Recent studies have identified high incidence and prevalence of delirium in various clinical samples
including general medicine (24.9%),3 cardiothoracic surgery
(21%),4 general surgery (24%),5 orthopaedic surgery (20%),6
critical care (30%)7 and the emergency unit.

Clinical features
In a patient presenting with a neuropsychiatric syndrome, the
diagnosis of delirium is suggested by an acute onset, a fluctuating

Aetiology
Delirium has a multi-factorial aetiology, so establishing the cause
of delirium is an important and challenging process. The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)8
classifies delirium depending on aetiology and divides it into
four different types: delirium due to general medical condition;

Screening tools and severity scales for delirium
Delirium screening tools
C

C
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Confusion Assessment
Method e CAM15
Delirium Symptom
Interview e DSI16
Cognitive Test for
Delirium e CTD17
Delirium Observation
Scale e DOS18

Severity scales for delirium
C
C

C
C

The Delirium Index e DI19
Memorial Delirium
Assessment Scale e MDAS20
Delirium-O-Metre e DOM21
Delirium Rating Scale
Revised 98 e DRS-R-9822

Table 2
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Figure 1
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treatment of delirium. Standard management and prevention of
delirium includes specific environmental interventions, and
physical and psychological management aimed at preventing or
correcting the underlying cause.25e28 However, there is limited
evidence from systematic studies, controlled trials or randomized
controlled trials for the treatment and management of delirium.29
A one-page evidence-based clinical management guideline was
developed as an ethical requirement for a randomized control
trial30 of treatment (Figure 1).

Mean doses for antipsychotics used in delirium

1
2
3
4

Medication

Range of mean dose (mg)

Olanzapine
Quetiapine
Risperidone
Haloperidol

4.52e4.54
40e113
1.02e1.19
1.71e7.06

Evidence for values provided by RCT data.

Prevention
Prophylactic effects of haloperidol31 and donepezil32 in delirium
have been studied in placebo-controlled studies. The evidence
for the use of medication to prevent delirium, and its ethics, are
debatable. Addressing the predisposing and precipitating aetiological factors may guide certain non-pharmacological preventative strategies and protect high-risk groups from developing
delirium.

Table 3

course and an underlying physical aetiology. There are three
motor subtypes: hypoactive (apathetic and withdrawn); hyperactive (agitated and distractible); and mixed (shifting between
hypoactive and hyperactive states).13 Core diagnostic features
include attention deficits (97e100%) and thought-process
abnormalities (54e79%). Other core symptoms include disorientation (76e96%), memory deficits (88e96%), sleepewake
cycle disruptions (92e97%), changes in motor behaviour
(24e94%) and language disturbances (57e67%). Non-core
symptoms include perceptual disturbances including hallucinations (50e63%), changes in mood (43e86%) and delusions
(21e31%).14
Screening tools for delirium exist and other tools can ascertain
severity (Table 2). Tools designed to assess cognitive impairment, although helpful in establishing the diagnosis of delirium,
are of limited value in the assessment of severity.

Treatment of symptoms
With detection and correction of the underlying cause, the
standard management of delirium includes non-pharmacological
and pharmacological treatment, but when and what drugs to use
remains uncertain, reflecting a lack of well-designed efficacy
studies.33 If non-pharmacological strategies do not work, the
NICE guideline recommends use of a low-dose antipsychotic
(olanzapine or haloperidol).34 Quetiapine may also be
used.30,35,36 It is noteworthy that there is no placebo-controlled
RCT evidence to support the use of haloperidol.29 To date there
are only three published placebo-controlled RCTs for treatment
of delirium using antipsychotics,30,35,36 only one of which took
place in a general hospital setting.37 Appropriate dosages, based
on information from various RCTs, are presented in Table 3. A
daily review for the first week is required to monitor progress
(Figure 1). If there is limited or no improvement the antipsychotic dosage can be increased slowly.
A

Natural history and prognosis
In a systematic review of the occurrence and outcome of
delirium, the death rate at discharge was reported to be
14.5e37%.1 Several risk factors for a poor outcome have been
identified. Medical causes such as stroke, Parkinson’s disease
and hypertension, along with demographic factors like female
sex and living alone, are independent risk factors of poor
outcome for activities of daily living in those who suffer from
dementia and develop delirium.23 Hypoactive delirium was reported to be associated with a poorer prognosis.
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A detailed medical history including information from a collateral source, physical examination and investigations should
aim to evaluate co-morbid physical disorders
Aetiological and risk factors, including predisposing features
and precipitating factors, guide a clinician in the management
of delirium
Non-pharmacological strategies, including educating nursing
staff, early medical consultation, mobilizing patients, monitoring their medication and making environmental and sensory
modifications, play an important role in reducing the chances
of developing delirium
A judicious use of a low-dose antipsychotic such as quetiapine,
olanzapine or haloperidol should be considered
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